http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112999211-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate | 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112999211-B |
| titleOfInvention | Application of ceramide molecules in the preparation of drugs for inhibiting metastasis of esophageal squamous cell carcinoma |
| abstract | The invention discloses the application of ceramide molecules in the preparation of drugs for inhibiting the metastasis of esophageal squamous cell carcinoma, and relates to the technical field of medical diagnosis. The above ceramide molecules are selected from ceramide Cer (d18:0/24:0) and Cer Any one of (d18:0/24:1), these two ceramide molecules can effectively inhibit the metastasis of human esophageal squamous cell carcinoma, which is safe and effective, and provides a new way for the clinical treatment of metastasis of esophageal squamous cell carcinoma . |
| priorityDate | 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.